Introductory Note to World Trade Organization Canada First Notice to Manufacture Generic Drug For Export

Introductory Note to World Trade Organization Canada First Notice to Manufacture Generic Drug For Export

  

46 International Legal Materials 1127 (2007)

Download Below

The Canadian Commissioner of Patents issued the first compulsory license for export to Apotex, Inc., a Canadian manufacturer of pharmaceutical products, pursuant to Canada's Access to Medicines Regime (CAMR) on September19, 2007.The license covers export to Rwanda, a least-developed African country, of a fixed dose combination of antiretroviral medicines used in the treatment of HIV-AIDS.

 

File: 

PDF icon Canada Compulsory License